News
Overweight women undertaking ART twice as likely to miscarry as their slimmer counterparts
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology, the 26th annual conference of the European Society of Human Reproduction and Embryology heard today. Dr. Vivian...
Screening for transmissible disease in ART patients not necessary at each donation
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) European legislation that requires all couples undergoing assisted reproduction treatment to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing...
Forma Therapeutics, Emerald BioStructures partner over drug development
June 28, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge small-molecule therapeutics developer Forma Therapeutics Inc. has partnered with Emerald BioStructures for the structure-based development of potential cancer drug targets.
Memories are made of this
June 28, 2010 7:35 am | by EurekAlert | Comments(University of Leicester) A new Wellcome Trust-funded study led by University of Leicester uncovers the key to how we learn and remember.
Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
June 28, 2010 7:32 am | by Bio-Medicine.Org | CommentsCHENGDU, China , June 28 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI ), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics will exhibit and promote its flagship product...
International study identifies 12 new genetic risk factors for type 2 diabetes
June 28, 2010 6:38 am | by EurekAlert | Comments(Helmholtz Zentrum München - German Research Center for Environmental Health) An international consortium including Helmholtz Zentrum Muenchen and the German Diabetes Center, Duesseldorf, has identified 12 new gene variants which impact the individual's risk of developing type 2...
Partners CIO Glaser heads to Siemens
June 28, 2010 6:38 am | by Mass High Tech: The Journal of New England Technology | CommentsSiemens Healthcare has hired away Partners Healthcare CIO John Glaser to head up its global healthcare IT business. The job change ends Glaser's tenure as CIO at Partners, which had lasted 15 years.
Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
June 28, 2010 6:37 am | by Bio-Medicine.Org | CommentsMAPLE GROVE, Minn. , June 28 /- Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's nasal midazolam. Under terms of the agreement, Upsher-Smith will assume all further development, testing...
New Data Demonstrates Victoza® (liraglutide rDNA injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at On...
June 28, 2010 6:36 am | by Bio-Medicine.Org | CommentsORLANDO, Fla. , June 28 /- Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily Victoza ® in combination with metformin produced sustained and...
New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
June 28, 2010 6:36 am | by Bio-Medicine.Org | CommentsPARSIPPANY, N.J. , June 28 /- Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a...
International child-health experts to converge on London for Excellence in Pediatrics
June 28, 2010 6:34 am | by EurekAlert | Comments(Wiley-Blackwell) Excellence in Pediatrics will provide an up-to-date and authoritative overview of pediatrics and child health through a variety of innovative sessions, designed for general and specialist health professionals. It will focus on four thematic streams: infectious...
New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)'s Effect on Bone Quality in Osteoporotic Patients
June 28, 2010 1:33 am | by Bio-Medicine.Org | CommentsMUNICH , June 28, 2010 /- - 3D Images Provide New Approach to Monitoring Bone Changes Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow , demonstrates that EVISTA(R) (raloxifene 60mg; once-d...
Combination MMRV Vaccine Associated with Two-Fold Risk of Febrile Seizures Compared with Separate MMR & Varicella Vaccines
June 27, 2010 10:35 pm | by Bio-Medicine.Org | CommentsOAKLAND, Calif. , June 28 /- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and...
Global Pharmaceutical R & D Productivity Declining According to Thomson Reuters, CMR International
June 27, 2010 10:35 pm | by Bio-Medicine.Org | CommentsPHILADELPHIA and LONDON , June 28 /- The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook complied...
Researchers develop accurate way to predict the age when women will hit the menopause
June 27, 2010 8:40 pm | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Researchers have developed a way of accurately predicting when women will hit the menopause using a simple blood test. The average difference between the predicted age and the actual age that the women in their study reached...
